Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 37.80
+0.40 (1.07%)
Jul 17, 2025, 11:44 AM CST
Polaris Group Company Description
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services.
The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications.
It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida.
Polaris Group
| Country | Cayman Islands |
| Founded | 1988 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 165 |
| CEO | Jaan-Pyng Hsu |
Contact Details
Address: 3030 N. Rocky Point Drive Tampa, 33607 United States | |
| Phone | 813 886 6500 |
| Website | polaris-group.com |
Stock Details
| Ticker Symbol | 6550 |
| Exchange | Taiwan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | KYG7171A1085 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jaan-Pyng Hsu | Chief Executive Officer and Chairman of the Board |
| Jack Fitzgibbons | President |
| Ray Wu | Chief Financial Officer |
| Yimingli Gao | Accounting Supervisor |
| Chien-Hsing Chang | Chief Strategy Officer |
| Kevin Wu | Chief Information Security Officer |